IMMUNOGENICITY, SAFETY AND REACTOGENICITY STUDY OF GLAXOSMITHKLINE (GSK) BIOLOGICALS' HIB-MENCY-TT (MENHIBRIX®) VACCINE COMPARED TO MERCK & CO, INC. PEDVAXHIB VACCINE IN HEALTHY INFANTS AND TODDLERS 12 TO 15 MONTHS OF AGE: